NEW YORK (Reuters Health) – Brentuximab vedotin can be safely combined with the second-line triple-agent chemotherapy regimen most commonly used in the U.S. for relapsed
Read more
Home » Health News »
NEW YORK (Reuters Health) – Brentuximab vedotin can be safely combined with the second-line triple-agent chemotherapy regimen most commonly used in the U.S. for relapsed
Read moreFirst off, congratulations on your recovery journey, it’s not easy. You should be proud of all that you have accomplished thus far. You are well
Read moreEditor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. President Joe Biden has expressed his support to Defense Secretary Lloyd
Read moreEditor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The FDA could fully approve Pfizer’s COVID-19 vaccine by the end
Read moreThe first generation vaccine developed by BioNTech-Pfizer works against coronavirus variants such as the Delta strain and does not need to be modified for the
Read moreSimone Biles is back home after the Olympics and it seems like she’s thrilled. The gymnast shared photos on Instagram of herself cheering on her
Read moreChildren's heavy digital media use is associated with a risk of being overweight later in adolescence. Physical activity protects children from the adverse effects of
Read moreAfter a year and a half of Zoom meetings, offices are reopening. Our laptops are no longer on our laps and our refrigerators aren’t around
Read moreA new research project aims to use personalized anti-rejection medication to reduce the health risks that organ transplant patients experience following surgery. Third-year Ph.D. student
Read moreIn late 2020, the US Food and Drug Administration (FDA) approved plasma kallikrein inhibitor berotralstat, making it the first oral, once-a-day treatment available for the
Read more